Correlation Between NeuroSense Therapeutics and Cingulate Warrants

Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Cingulate Warrants, you can compare the effects of market volatilities on NeuroSense Therapeutics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Cingulate Warrants.

Diversification Opportunities for NeuroSense Therapeutics and Cingulate Warrants

-0.28

Correlation Coefficient

NeuroSense Therapeutics  Cingulate Warrants

Very good diversification

The 3 months correlation between NeuroSense and Cingulate is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Cingulate Warrants go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and Cingulate Warrants

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 10.7 times more return on investment than Cingulate Warrants. However, NeuroSense Therapeutics is 10.7 times more volatile than Cingulate Warrants. It trades about 0.21 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.07 per unit of risk. If you would invest  0.00  in NeuroSense Therapeutics Ltd on September 4, 2024 and sell it today you would earn a total of  25.00  from holding NeuroSense Therapeutics Ltd or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	48.39%
Values	Daily Returns

NeuroSense Therapeutics Ltd  vs.  Cingulate Warrants

NeuroSense Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Cingulate Warrants

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuroSense Therapeutics and Cingulate Warrants

The main advantage of trading using opposite NeuroSense Therapeutics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.

The idea behind NeuroSense Therapeutics Ltd and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.